Jayant Aphale Net Worth & Insider Trades

Jayant Aphale - VP, Sarepta Therapeutics, Inc

As of September 21, 2016

What is Jayant Aphale's Net Worth?

The current estimated net worth of Sarepta Therapeutics, Inc's VP, Jayant Aphale, is estimated to be about $3.73M . Jayant Aphale owns about 11,490 units of Sarepta Therapeutics, Inc common stock. In the last 3 years at Sarepta Therapeutics, Inc, Jayant Aphale has sold an estimated value of $1.97M worth.

What is Jayant Aphale's Past Insider Trading?

Jayant Aphale's largest purchase order was 35,000 units , worth over $161.7K on September 21, 2016. Jayant Aphale's largest sale order was 35,000 units , worth over $1.75M on September 21, 2016. In total, Jayant Aphale has made about 7 transactions over 3 years of their time at Sarepta Therapeutics, Inc. Jayant Aphale usually trades in March, with the busiest year in 2016.

Jayant Aphale

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Jayant Aphale's' Mailing Address?

  • Mailing address is 215 First Street Suite 7 Cambridge MA 02142 MA

Sarepta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Douglas S. Ingram 2020 $669,250 - $17,222 $17,222 $17,222 $1,291,947
Douglas S. Ingram 2019 $650,000 - $5,822 $5,822 $5,822 $1,387,072
Douglas S. Ingram 2018 $650,000 - $5,822 $5,822 $5,822 $1,433,872
Ian M. Estepan 2020 $445,822 $434,986 $32,744 $32,744 $32,744 $5,177,681
Ian M. Estepan 2019 - - - - - -
Ian M. Estepan 2018 - - - - - -
Gilmore O'Neill, M.B., M.M.Sc. 2020 $583,277 $766,949 $15,500 $15,500 $15,500 $3,790,049
Gilmore O'Neill, M.B., M.M.Sc. 2019 $563,962 - $15,300 $15,300 $15,300 $5,168,110
Gilmore O'Neill, M.B., M.M.Sc. 2018 $310,962 $1,154,760 $2,050 $2,050 $2,050 $6,449,176
William Ciambrone 2020 $458,179 - $14,500 $14,500 $14,500 $679,938
William Ciambrone 2019 $51,346 - $1,000 $1,000 $1,000 $4,345,194
William Ciambrone 2018 - - - - - -
Louise Rodino-Klapac, Ph.D. 2020 $495,590 $766,949 $13,532 $13,532 $13,532 $7,269,509
Louise Rodino-Klapac, Ph.D. 2019 - - - - - -
Louise Rodino-Klapac, Ph.D. 2018 - - - - - -
Joseph Bratica 2020 $326,028 $237,525 $11,645 $11,645 $11,645 $911,887
Joseph Bratica 2019 - - - - - -
Joseph Bratica 2018 - - - - - -
Sandesh Mahatme 2020 $312,835 $766,949 $39,413 $39,413 $39,413 $3,364,021
Sandesh Mahatme 2019 $557,327 - $14,840 $14,840 $14,840 $5,161,209
Sandesh Mahatme 2018 $498,112 - $24,838 $24,838 $24,838 $4,219,084
David Tyronne Howton, Jr. 2020 $470,695 $1,050,929 $157,280 $157,280 $157,280 $5,703,078
David Tyronne Howton, Jr. 2019 $458,844 - $13,318 $13,318 $13,318 $4,196,622
David Tyronne Howton, Jr. 2018 $438,185 - $13,118 $13,118 $13,118 $3,129,375
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm

What are Sarepta Therapeutics, Inc's Past Insider Trades?

Sarepta Therapeutics, Inc's most recent insider trade came on November 21, 2022 by Stephen Mayo who sold 858 units worth $94.31K . In the last 10 years, insiders at Sarepta Therapeutics, Inc have sold an estimated value of $177.49M and bought an estimated value of $53.33M worth of shares. Insider trading is most common in March, with the busiest year in 2017. The most active traders at the company are Sandesh Mahatme, EVP,  David T Howton, EVP,  and Edward M. Kaye, Director .

Sarepta Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...